Full text is available at the source.
Abstract
High expression of the cGAS-STING pathway and abundant mitochondrial DNA (mtDNA) are features of KRAS-mutant cancers.
- Mitochondrial stress can lead to apoptosis or immune activation in cancer cells.
- In KRAS-mutant cancer cells, a MEK inhibitor effectively triggers mtDNA release into the cytosol.
- PRKN-mediated mitophagy limits mtDNA release by removing damaged mitochondria.
- Inhibition of mitophagy enhances mtDNA efflux and amplifies cGAS-STING signaling.
- The balance of mtDNA and cytochrome c release determines whether immunogenic cell death or apoptosis occurs.
- In preclinical models, combined targeting of MEK and mitophagy promotes dendritic cell activation and CD8+ T cell immunity.
Simplified